OptimizeRx
OPRX
OPRX
127 hedge funds and large institutions have $205M invested in OptimizeRx in 2022 Q3 according to their latest regulatory filings, with 26 funds opening new positions, 37 increasing their positions, 42 reducing their positions, and 45 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
42% less first-time investments, than exits
New positions opened: 26 | Existing positions closed: 45
52% less capital invested
Capital invested by funds: $428M → $205M (-$224M)
67% less funds holding in top 10
Funds holding in top 10: 3 → 1 (-2)
Holders
127
Holding in Top 10
1
Calls
$14.7M
Puts
$1.52M
Top Buyers
| 1 | +$6.03M | |
| 2 | +$4.61M | |
| 3 | +$3.51M | |
| 4 |
Two Sigma Investments
New York
|
+$3.06M |
| 5 |
IP
Invenire Partners
Ridgefield,
Connecticut
|
+$1.56M |
Top Sellers
| 1 | -$19.3M | |
| 2 | -$16.9M | |
| 3 | -$14M | |
| 4 |
GIP
Granite Investment Partners
El Segundo,
California
|
-$10.9M |
| 5 |
LCG
Lisanti Capital Growth
New York
|
-$4.95M |